Drug or chemical induced diabetes mellitus with proliferative diabetic retinopathy with traction retinal detachment involving the macula (left eye)
ICD-10 E09.3522 is a billable code used to indicate a diagnosis of drug or chemical induced diabetes mellitus with proliferative diabetic retinopathy with traction retinal detachment involving the macula (left eye).
E09.3522 refers to diabetes mellitus that is induced by drugs or chemicals, leading to significant complications such as proliferative diabetic retinopathy (PDR) and traction retinal detachment affecting the macula of the left eye. Drug-induced diabetes can arise from various medications, including corticosteroids, antipsychotics, and certain chemotherapy agents. Proliferative diabetic retinopathy is characterized by the growth of new blood vessels on the retina, which can lead to severe vision impairment. The presence of traction retinal detachment indicates that these new vessels have caused pulling on the retina, particularly affecting the macula, which is crucial for central vision. Management of this condition often involves controlling blood glucose levels, monitoring HbA1c levels, and potentially surgical intervention for the retinal detachment. The complexity of this diagnosis lies in the multifactorial nature of diabetes management and the need for careful monitoring of both metabolic and ocular health.
Detailed medication history, HbA1c levels, and diabetes management plans.
Patients with diabetes requiring insulin management and monitoring for complications.
Ensure clear documentation of drug-induced nature and its impact on diabetes control.
Detailed retinal examination findings, imaging results, and treatment plans for retinopathy.
Patients presenting with vision changes due to diabetic retinopathy.
Document the extent of retinal detachment and any surgical interventions performed.
Used for treatment of proliferative diabetic retinopathy.
Document the extent of laser treatment and follow-up care.
Ophthalmology should ensure clear documentation of the procedure and its necessity.
Specifying the eye affected is crucial for treatment planning and understanding the severity of the condition, as it impacts management strategies and potential surgical interventions.
